Over the course of this year, the IP landscape for drug and device companies in Australia has the potential to change quite dramatically. These changes picked up speed last month when the Intellectual Property Laws Amendment (Raising the Bar) Bill 2011 was passed by the Australian Senate.
The Bill now awaits passage through the House of Representatives. The bill is expected to receive final approval by the middle of the year and go into effect in 2013.
If and when it is green-lighted, it will amend patent, trademark, and other intellectual property laws. Together with detailed regulations, the new law will have a significant impact on medical device and pharmaceutical companies' IP practice in Australia.
An excellent summary of the likely impact of the bill can be seen on the web site of Mallesons Stephen Jaques - take a look here.
[Hat tip to @Pharma_Life_Law]
Haven't yet had your daily fix of patents and trademarks? No worries - take a look at the following:
- Global Patent Standards
- Managing the risk of patent translation
- EPO tries to strike balance between pragmatism and linguistic pluralism
ForeignExchange provides expert medical translations for medical device and pharmaceutical patents and other IP. Ask us for a detailed proposal on your next translation assignment.